“janssen-biotech” Archives

in
Entry Author Date Location
GlaxoSmithKline Multiple Myeloma Drug Earns FDA’s First Anti-BCMA Nod 08/06/20 National
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
AbbVie Commits $750M to Genmab Bispecific Antibody Cancer Drug Deal 06/10/20 National
Legend Biotech’s Upsized IPO Lands $424M for Multiple Myeloma Drug 06/05/20 New York
From Overseas, Legend Biotech and Calliditas Therapeutics Eye the Nasdaq 05/15/20 New York
Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More 04/03/20 National
Aduro Biotech Slashes Staff 37%, Turns Focus to Lead Cancer Drugs 01/30/19 San Francisco
Gates Foundation, Bristol-Myers Join $27M Funding for Vedanta Bio 12/24/18 Boston
Bio Roundup: Nobel Prizes, Duchenne Steps, Guardant’s IPO & More 10/05/18 National
Bio Roundup: Amarin’s Stunner, Lung Cancer News, Data Dumps & More 09/28/18 National
Geron’s Drug Alliance with Janssen Terminated, Shares Plummet 68% 09/27/18 San Francisco
Theravance Snares $100M From Janssen in Stomach Drug Deal 02/07/18 San Francisco
Halozyme Inks $105M Bristol-Myers Partnership, Expands Roche Deal 09/14/17 San Diego
SetPoint Nabs $30M For More Tests of Bioelectric Device as RA Therapy 08/28/17 San Francisco
Tesaro Cashes In Again on PARP Blocker With $100M Takeda Deal 07/27/17 Boston
Bio Roundup: PDUFA Progress, BCRA Redux, CAR-T Thumbs Up, & More 07/14/17 National
Protagonist, Janssen Ink Development Deal for Crohn’s Disease Drug 05/30/17 San Francisco
ViaCyte Reports on Stem Cell Diabetes Trial, Absorbs BetaLogics 02/04/16 San Diego
Aduro Lands New Berkeley Life Sciences Digs, with Room to Grow 09/18/15 San Francisco
Novartis Bets $250M-Plus on Aduro’s Immuno-Oncology Work 03/30/15 San Francisco
Vascular Pharmaceuticals Lands $9M For Diabetes Drug Trials 03/03/15 Raleigh Durham
With Vedanta Deal, J&J Marks Big-Pharma Milestone in the Microbiome 01/13/15 Boston
West Coast Biotech Roundup: Hep C, 23andMe, Kite, Cash, Isis & More 01/08/15 San Francisco
West Coast Biotech Roundup: Gilead/AbbVie, Juno, Auspex, Bina & More 12/23/14 San Francisco
West Coast Biotech Roundup: Gilead, Juno, Hutch, Fibrogen & More 11/20/14 Seattle
In Its Bumpy Second Life, Geron Signs Top Drug Over to J&J 11/13/14 San Francisco
Scholar Rock’s Local Approach to Immune Disease Nabs $20M 09/15/14 Boston
With J&J Deals, Aduro’s Cancer Vaccines Have New Chance To Prove Worth 06/18/14 San Francisco
MD Anderson Expands “Moon Shots” Immunotherapy Partnership to J&J 01/21/14 Texas
Using Frugal Business Model, Orphagen Targets Orphan Receptors 06/13/13 San Diego
Page 1 of 2 next page »